[Form 4] Veracyte, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Veracyte, Inc. (VCYT) – Form 4 Insider Filing

Director Thomas F. Miller reported the award of 9,321 restricted stock units (RSUs) on 18 June 2025. The RSUs were granted at no cost as part of routine director compensation and will vest in full on the first anniversary of the grant date or immediately before the company’s next annual shareholders’ meeting, whichever occurs first. Vesting also accelerates upon a change in control. Following the grant, Miller’s direct beneficial ownership increased to 25,828 common shares. No open-market purchases, sales, or derivative transactions were disclosed. The filing represents a standard equity compensation event and results in only immaterial dilution relative to Veracyte’s total shares outstanding.

Insights

Corporate Governance Analyst

TL;DR: Routine RSU grant; neutral governance and valuation impact.

The Form 4 discloses a standard annual equity award to Director Thomas F. Miller. Because the shares were granted at $0 and not acquired on the open market, the transaction offers limited signaling value regarding management’s expectations for future performance. It modestly aligns director incentives with shareholder interests but adds only 9,321 shares, an immaterial percentage of Veracyte’s outstanding equity. No red flags on timing, volume, or accelerated vesting provisions were noted beyond standard change-of-control protection. Overall governance and dilution impact are negligible.

Portfolio Manager

TL;DR: Minor, non-cash insider acquisition – not a trading signal.

From an investment perspective, this is a neutral event. The director’s ownership rose to 25,828 shares, but the method was a no-cost RSU grant, not an open-market buy that would imply valuation conviction. The 9,321-share award is statistically insignificant versus Veracyte’s float and will have no discernible effect on EPS or liquidity. I classify the disclosure as not impactful for portfolio positioning.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miller Thomas F.

(Last) (First) (Middle)

6000 SHORELINE COURT

SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		A(1)		9,321	A	$0	25,828	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What SEC form did Veracyte (VCYT) file on 23 June 2025?

The company filed a Form 4 reporting insider transactions by Director Thomas F. Miller.

How many restricted stock units were granted to Director Thomas F. Miller?

He received 9,321 RSUs.

When will the newly granted RSUs vest?

They vest in full on the first anniversary of 18 June 2025 or immediately before the next annual meeting, whichever comes first.

What is Miller’s total beneficial ownership after the grant?

His direct shareholding increased to 25,828 common shares.

Were there any open-market purchases or sales disclosed?

No. The filing only reports a no-cost equity grant; no purchases or sales were made.

Does the award accelerate upon a change in control?

Yes. The RSUs fully vest if a change in control occurs before the normal vesting date.